Modulatory effect of sildenafil in diabetes and electroconvulsive shock-induced cognitive dysfunction in rats

Pharmacological Reports

Volumn 58, Issue 3, 2006, Pages 373-380

  Patil, Chandrashekhar S ^a   Singh, Vijay Pal ^b   Kulkarni, Shrinivas K ^b  

^a Panacea Biotec Ltd   (India)

^b PANJAB UNIVERSITY   (India)

Author keywords

Cognition; Diabetes; Electroconvulsive shock; Sildenafil

Indexed keywords

CYCLIC GMP; GUANYLATE CYCLASE INHIBITOR; METHYLENE BLUE; N(G) NITROARGININE METHYL ESTER; NITRIC OXIDE SYNTHASE; NITRIC OXIDE SYNTHASE INHIBITOR; PHOSPHODIESTERASE V; PHOSPHODIESTERASE V INHIBITOR; SILDENAFIL; STREPTOZOCIN;

ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; BLOOD PRESSURE MEASUREMENT; COGNITION; COGNITIVE DEFECT; CONTROLLED STUDY; DEGENERATIVE DISEASE; DIABETES MELLITUS; DRUG EFFECT; ELECTRIC SHOCK; LEARNING; LOCOMOTION; MAZE TEST; NEUROPROTECTION; NON INVASIVE MEASUREMENT; NONHUMAN; PASSIVE AVOIDANCE; RAT; SHORT COURSE THERAPY; TASK PERFORMANCE;

EID: 33746381229     PISSN: 22995684     EISSN: 22995684     Source Type: Journal    
DOI: None     Document Type: Article

References (31)

1. Beavo JA: Cyclic nucleotide phosphodiesterases functional implications of multiple isoforms. Physiol Rev, 1995, 75, 725-745.
2. Bohme GA, Bon C, Stutzmann JM, Doble A, Blanchard JC: Possible involvement of nitric oxide in long-term potentiation. Eur J Pharmacol, 1991, 199, 379-381.
3. Bredt DS, Hwang PM, Snyder SH: Localization of nitric oxide synthase indicating a neural role for nitric oxide. Nature, 1990, 347, 768-770.
4. Brune B, Lapetina EG: Activation of a cytosolic ADP-ribosyltransferase by nitric oxide-generating agents. J Biol Chem, 1989, 264, 8455-8458.
5. Casamenti F, Scali C, Vannucchi MG, Bartolini L, Pepeu G: Long-term ethanol consumption by rats: effect on acetylcholine release in vivo, choline acetyltransferase activity and behaviour. Neuroscience, 1993, 56, 465-471.
6. Cho CH, Cho DH, Seo MR, Juhnn YS: Differential changes in the expression of cyclic nucleotide phosphodiesterase isoforms in rat brains by chronic treatment with electroconvulsive shock. Exp Mol Med, 2000, 32, 110-114.
7. Conti M, Jin SL: The molecular biology of cyclic nucleotide phosphodiesterases. Prog Nucl Acid Res Mol Biol, 2000, 63, 1-38.
8. Dinerman JL, Steiner JP, Dawson TM, Dawson V, Snyder SH: Cyclic nucleotide dependent phosphorylation of neuronal nitric oxide synthase inhibits catalytic activity. Neuropharmacology, 1994, 33, 1245-1251.
9. R tablets (sildenafil citrate). Review and evaluation of pharmacology and toxicology data. Report from the Division of Cardio-renal drug products (HFD-10). Centre for Drug Evaluation and Research. Washington, DC: Food and Drug Administration. 1998, 121-122.
10. Garthwaite J, Charles SL, Chess-Williams R: Endothelium- derived relaxing factor release on activation of NMDA receptors suggests role as intercellular messenger in the brain. Nature, 1988, 336, 385-388.
11. Haley JE, Dickenson AH, Schachter M: Electrophysiological evidence for a role of nitric oxide in prolonged chemical nociception in the rat. Neuropharmacology, 1992, 31, 251-258.
12. Houslay MD, Milligan G:. Tailoring cAMP-signalling responses through isoform multiplicity. Trends Biochem Sci, 1997, 22, 217-224.
13. Jain NK, Patil CS, Singh A, Kulkami SK: Sildenafil induces peripheral analgesia and activation of the nitric oxide-cyclic GMP pathway. Brain Res, 2001, 909, 170-178.
14. Kotera J, Fujishige K, Omori K: Immunohistochemical localization of cGMP-binding cGMP-specific phosphodiesterase (PDE5) in rat tissues. J Histochem Cytochem, 2000, 48, 685-693.
15. Kotera J, Yanka N, Fujishige K, Imai Y, Akatsuka H, Ishizuika T, Kawashima K, Omori K: Expression of rat cGMP-binding cGMP-specific phosphodiesterase mRNA in Purkinje cell layers during postnatal neuronal development. Eur J Biochem, 1997, 249, 434-442.
16. Murphy S: Production of nitric oxide by glial cells: regulation and potential roles in the CNS. Glia, 2000, 29, 1-13.
17. O'Dell TJ, Kandel ER, Grant SG: Long-term potentiation in the hippocampus is blocked by tyrosine kinase inhibitors. Nature, 1991, 353, 558-550.
18. Patil CS, Jain NK, Singh VP, Kulkarni SK: Differential effect of PDE5 inhibitors, sildenafil and zaprinast in aging- and lipopolysaccharide-induced cognitive dysfunction in mice. Drug Dev Res, 2004, 63, 66-75.
19. Pellow S, Chopin P, File SE, Briley M: Validation of open:closed arm entries in an elevated plus-maze as a measure of anxiety in the rat. J Neurosci Methods, 1985, 14, 149-167.
20. Reagan LP, McEwen BS: Diabetes, but not stress, reduces neuronal nitric oxide synthase expression in rat hippocampus: implications for hippocampal synaptic plasticity. Neuroreport, 2002, 13, 1801-1804.
21. Reddy DS, Kulkarni SK: Possible role of nitric oxide in the nootropic and antiamnesic effects of neurosteroids on aging- and dizocilipine-induced learning impairment. Brain Res, 1998, 799, 215-229.
22. 2+-independent nitric oxide synthases. FEBS Lett, 1991, 291, 145-149.
23. Schuman EM, Madison DV: A requirement for the intercellular messenger nitric oxide in long-term potentiation. Science, 1991, 254, 1503-1506.
24. 2+ signalling pathways. Exp Mol Med, 1999, 31, 42-46.
25. Sindrup SH, Ejlertsen B, Gjessing H, Froland A, Sindrup EH: Peripheral nerve functions during hyperglycemic clamping in healthy subjects. Acta Neurol Scand, 1988, 78, 141-145.
26. Singh VP, Jain NK, Kulkarni SK: On the antinociceptive effect of fluoxetine, a selective serotonin reuptake inhibitor. Brain Res, 2001, 915, 218-226.
27. Soderling TR: CaM-kinases: modulators of synaptic plasticity. Curr Opin Neurobiol 2000, 10, 375-380.
28. Sole-Padulles C, Bartres-Faz D, Junque C, Via M, Matarin M, Gonzalez-Perez E, Moral P et al.: Poorer cognitive performance in humans with mild cognitive impairment carrying the T variant of the Glu/Asp NOS3 polymorphism. Neurosci Lett, 2004, 18, 358, 5-8.
29. Sommerfield AJ, Deary IJ, Frier BM: Acute hyperglycemia alters mood state and impairs cognitive performance in people with type 2 diabetes. Diabetes Care, 2004, 27, 2335-2340.
30. Watkins CC, Sawa A, Jaffrey S, Blackshaw S, Barrow RK, Snyder SH, Ferris CD: Insulin restores neuronal nitric oxide synthase expression and function that is lost in diabetic gastropathy. J Clin Invest, 2000, 106, 373-384.
31. Wiencken AE, Casagrande VA: Endothelial nitric oxide synthetase (eNOS) in astrocytes: another source of nitric oxide in neocortex. Glia, 1999, 26, 280-290.